Cosmo Pharmaceuticals S.p.A., Valeant Pharmaceuticals deal

Cosmo and Valeant amended an April 2012 deal that granted Medicis Pharmaceutical Corp., now part of Valeant, exclusive, worldwide rights to develop and commercialize CB-03-01 for all indications. Un...